We are pleased to announce that our team will be attending the 28th ESGCT Annual Meeting to be held virtually October 19-22, 2021
The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technoloy and by serving as a professional adviser to skateholder communities and regulatory bodies in Europe.
Our team, available on line:
-Régis Gayon, Vectorology and Cell Engineering Project Manager
-Christine Duthoit, Immunology and Cell Engineering Project Manager
-Marlayna Sterner, Sales Engineer
-Stéphane Carrasco, Industrial Development Manager
Our team will also be presenting 2 posters:
"Same lentiviral vector manufacturing process for both research and clinical applications"
Poster ID: P287
"Efficient and safe delivery of multiple mRNA using non-integrative bacteriophage-chimeric retrovirus-like particles for cell therapy and vaccination perspectives"
Poster ID: P196
If you would like to set up an appointment with us, please contact us on our website or call us at + 33 5 82 95 55 46.
Looking forward to meet you.